Secondary analysis of 437 patients with muscle-invasive bladder cancer given neoadjuvant chemotherapy and cystectomy in a trial: creatinine clearance, lymphovascular and perineural invasion and basal molecular subtype were prognostic for overall survival.
Secondary analysisn = 437
Pfister et al. Prognostic Factors for Overall Survival in the VESPER Trial: Basal Molecular Subtype Is a Relevant Key Factor